4//SEC Filing
VANLENT ANNE 4
Accession 0001437749-19-012107
CIK 0000072444other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 5:01 PM ET
Size
7.6 KB
Accession
0001437749-19-012107
Insider Transaction Report
Form 4
Vaxart, Inc.VXRT
VANLENT ANNE
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-12+12,700→ 12,700 totalExercise: $0.68From: 2020-04-22Exp: 2029-06-11→ Common Stock (12,700 underlying) - Award
Stock Option (right to buy)
2019-06-12+9,000→ 9,000 totalExercise: $0.68Exp: 2029-06-11→ Common Stock (9,000 underlying)
Footnotes (2)
- [F1]The shares subject to this option shall vest annually over three years from the vesting commencement date of February 13, 2018 (the closing date of the merger between privately-held Vaxart, Inc. and Aviragen Therapeutics, Inc.).
- [F2]The shares subject to this option shall vest on the first anniversary of the 2019 annual meeting of stockholders of the Issuer.
Documents
Issuer
Vaxart, Inc.
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001229243
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 5:01 PM ET
- Size
- 7.6 KB